Home › Calculator › ZBH Dividend Calculator 2026
ZBH DRIP Calculator & Dividend Yield 2026
0.97% YieldHealthcareZimmer Biomet Holdings, Inc. · NYSE
Price: $98.56 · Annual div: $0.9600/share · Frequency: quarterly · Payout ratio: 27% · Ex-div: 2026-09-30
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ZBH pays your bills
Year your monthly dividend income covers each expense (based on current settings)
ZBH Dividend History — Last 59 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-30Latest | 2026-10-30 | $0.2400 | 0.97% | $99.40 |
| 2026-06-25 | 2026-07-31 | $0.2400 | 1.45% | $82.94 |
| 2026-03-31 | 2026-04-30 | $0.2400 | 0.96% | $99.49 |
| 2025-12-30 | 2026-01-30 | $0.2400 | 1.01% | $94.76 |
| 2025-09-30 | 2025-10-31 | $0.2400 | 0.91% | $105.01 |
| 2025-06-26 | 2025-07-31 | $0.2400 | 1.05% | $91.11 |
| 2025-03-31 | 2025-04-30 | $0.2400 | 0.91% | $105.38 |
| 2024-12-30 | 2025-01-31 | $0.2400 | 0.87% | $110.50 |
| 2024-09-30 | 2024-10-31 | $0.2400 | 0.83% | $116.17 |
| 2024-06-26 | 2024-07-31 | $0.2400 | 0.85% | $113.12 |
| 2024-03-27 | 2024-04-30 | $0.2400 | 0.77% | $124.01 |
| 2023-12-26 | 2024-01-31 | $0.2400 | 0.81% | $117.97 |
| 2023-09-28 | 2023-10-31 | $0.2400 | 1.00% | $119.45 |
| 2023-06-23 | 2023-07-31 | $0.2400 | 0.94% | $127.36 |
| 2023-03-28 | 2023-04-28 | $0.2400 | 0.79% | $122.08 |
| 2022-12-23 | 2023-01-31 | $0.2400 | 0.97% | $123.35 |
| 2022-09-29 | 2022-10-31 | $0.2400 | 0.89% | $106.80 |
| 2022-06-24 | 2022-07-29 | $0.2400 | 0.99% | $119.28 |
| 2022-03-28 | 2022-04-29 | $0.2400 | 0.76% | $124.14 |
| 2021-12-27 | 2022-01-31 | $0.2330 | 0.80% | $116.21 |
| 2021-09-29 | 2021-10-29 | $0.2330 | 0.64% | $146.36 |
| 2021-06-25 | 2021-07-30 | $0.2330 | 0.72% | $161.25 |
| 2021-03-26 | 2021-04-30 | $0.2330 | 0.59% | $158.52 |
| 2020-12-24 | 2021-01-29 | $0.2330 | — | — |
| 2020-09-29 | 2020-10-30 | $0.2330 | — | — |
| 2020-06-26 | 2020-07-31 | $0.2330 | — | — |
| 2020-03-26 | 2020-04-30 | $0.2330 | — | — |
| 2019-12-26 | 2020-01-31 | $0.2330 | — | — |
| 2019-09-27 | 2019-10-31 | $0.2330 | — | — |
| 2019-06-27 | 2019-07-31 | $0.2330 | — | — |
| 2019-03-28 | 2019-04-30 | $0.2330 | — | — |
| 2018-12-27 | 2019-01-31 | $0.2330 | — | — |
| 2018-09-27 | 2018-10-31 | $0.2330 | — | — |
| 2018-06-28 | 2018-07-31 | $0.2330 | — | — |
| 2018-03-28 | 2018-04-30 | $0.2330 | — | — |
| 2017-12-28 | 2018-01-29 | $0.2330 | — | — |
| 2017-09-21 | 2017-10-27 | $0.2330 | — | — |
| 2017-06-21 | 2017-07-28 | $0.2330 | — | — |
| 2017-03-29 | 2017-04-28 | $0.2330 | — | — |
| 2016-12-28 | 2017-01-27 | $0.2330 | — | — |
| 2016-09-21 | 2016-10-28 | $0.2330 | — | — |
| 2016-06-22 | 2016-07-29 | $0.2330 | — | — |
| 2016-03-29 | 2016-04-29 | $0.2330 | — | — |
| 2015-12-29 | 2016-01-29 | $0.2136 | — | — |
| 2015-09-28 | 2015-10-30 | $0.2136 | — | — |
| 2015-05-13 | 2015-07-14 | $0.2136 | — | — |
| 2015-03-04 | 2015-04-24 | $0.2136 | — | — |
| 2014-12-24 | 2015-01-30 | $0.2136 | — | — |
| 2014-09-24 | 2014-10-31 | $0.2136 | — | — |
| 2014-06-25 | 2014-07-25 | $0.2136 | — | — |
| 2014-03-26 | 2014-04-25 | $0.2136 | — | — |
| 2013-12-24 | 2014-01-31 | $0.1942 | — | — |
| 2013-09-25 | 2013-10-25 | $0.1942 | — | — |
| 2013-06-26 | 2013-07-26 | $0.1942 | — | — |
| 2013-03-26 | 2013-04-26 | $0.1942 | — | — |
| 2012-12-24 | 2013-01-25 | $0.1748 | — | — |
| 2012-09-25 | 2012-10-26 | $0.1748 | — | — |
| 2012-06-26 | 2012-07-27 | $0.1748 | — | — |
| 2012-03-28 | 2012-04-27 | $0.1748 | — | — |
About Zimmer Biomet Holdings, Inc. (ZBH) — Dividend Analysis 2026
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Similar dividend stocks to ZBH
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ZBH DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ZBH position with:
🌍 ZBH Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ZBH.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.97% | -1.83% | $97 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.82% | -1.98% | $82 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.78% | -2.02% | $78 / yr |
| 🇬🇧 UK ISA | 0% | 0.97% | -1.83% | $97 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.89% | -1.91% | $89 / yr |
| 🇨🇦 TFSA | 0% | 0.97% | -1.83% | $97 / yr |
| 🇨🇦 CA Taxable | 25% | 0.73% | -2.07% | $73 / yr |
| 🇦🇺 Super (pension) | 15% | 0.82% | -1.98% | $82 / yr |
| 🇦🇺 AU Taxable | 30% | 0.68% | -2.12% | $68 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.71% | -2.09% | $71 / yr |
| 🇫🇷 FR Taxable | 30% | 0.68% | -2.12% | $68 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ZBH Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.96/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ZBH Dividend Payment Schedule
ZBH pays quarterly — 4 times per year. Ex-div: 2026-09-30.
📊 ZBH vs Healthcare Benchmarks
How ZBH compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ZBH sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ZBH Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-10-01 | 1,218 | — | — | ||
| M-Exempt | 2026-10-01 | 1,218 | — | — | ||
| M-Exempt | 2026-10-01 | 2,368 | — | — | ||
| F-InKind | 2026-10-01 | 480 | $88.42 | $42.4K | ||
| F-InKind | 2026-10-01 | 932 | $88.42 | $82.4K | ||
| M-Exempt | 2026-10-01 | 2,368 | — | — | ||
| Other | 2026-10-01 | 1,407 | $111.14 | $156.4K | ||
| Other | 2026-10-01 | 857 | $111.03 | $95.2K | ||
| Other | 2026-10-01 | 6,201 | — | — | ||
| Other | 2026-10-01 | 2,156 | $120.04 | $258.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ZBH with peers: ZBH vs DGX · ZBH vs DXCM · ZBH vs ILMN
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where ZBH earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ZBH dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Zimmer Biomet Holdings, Inc. (ZBH) is currently trading at $98.56, 5% below its 52-week high. The current dividend yield is 0.97% based on an annual payout of $0.9600 per share.
Zimmer Biomet offers exceptional dividend safety but lacks growth momentum
AI SummaryZimmer Biomet Holdings, Inc. presents a stable income profile within the healthcare sector, trading at $88.49 with a market capitalization of $17.1 billion. The company supports a modest 1.08% dividend yield via an annual payout of $0.96. Dividend safety is exceptionally strong, backed by a conservative payout ratio of just 27% and a reasonable P/E ratio of 24.9, ensuring the distribution is well-covered by current earnings. However, the income growth trajectory remains stagnant for long-term investors. The 5-year dividend CAGR sits at 0%, reflecting management's cautious capital allocation strategy rather than aggressive distribution expansion. While the existing payout is highly sustainable and protected by steady cash flows, income-focused investors should not expect meaningful near-te
- Stagnant dividend growth history with a 0% five-year CAGR
- Modest dividend yield may fail to satisfy income-seeking investors
Generated by AI using live market data. For educational purposes only — not financial advice.
Latest ZBH News
LiveHow investors use the ZBH dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.